wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35803226-08EC8B16-37B4-4EF0-8870-284DCB856B67
Q35803226-08EC8B16-37B4-4EF0-8870-284DCB856B67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803226-08EC8B16-37B4-4EF0-8870-284DCB856B67
Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.
P2860
Q35803226-08EC8B16-37B4-4EF0-8870-284DCB856B67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803226-08EC8B16-37B4-4EF0-8870-284DCB856B67
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0513484969c17eea9af8c3c549de7e722d33f4db
P2860
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.